Biocon Biologics
Bangalore, IN
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-02
77.1
Signal Score
✓ FDA Inspections (3)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Biocon Biologics
- Signal Score
- 77.1/100 (as of 2026-04-02)
- Quality Compliance
- 96.0/100
- Headquarters
- Bangalore, IN
- Modalities
- Cell Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
96.0
FDA Inspections3 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2025-09-03)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
68.0
Parent company: Biocon
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Biocon
Financial assessment: 68.0/100
Capacity
53.0
1 manufacturing site: Bangalore, IN
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Sites: Bangalore, IN
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Bangalore, IN
Modalities: Cell Therapy
Capacity assessment: 53.0/100
FDA Inspection History
2025-09
2024-09
2024-07
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-09-03 | Bengaluru | Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2024-09-20 | Bangalore | Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2024-07-26 | Bengaluru | Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Apr 05, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Syngene International
Bangalore, IN
Signal Score: 81.6
Biologics, Cell Therapy
Intas Pharmaceuticals
Ahmedabad, IN
Signal Score: 76.8
Cell Therapy
Singota Solutions
Bloomington, IN
Signal Score: 59.0
Cell Therapy, Biologics
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 90.7
CAR-T, Cell Therapy